Experimental evidence of oxidative stress in plasma of homocystinuric patients: A possible role for homocysteine

Molecular Genetics and Metabolism

Volumn 104, Issue 1-2, 2011, Pages 112-117

  Vanzin, Camila Simioni ^a,b   Biancini, Giovana Brondani ^a,b   Sitta, Angela ^a,b   Wayhs, Carlos Alberto Yasin ^a,b   Pereira, Izabela Netto ^b   Rockenbach, Francieli ^a   Garcia, Solange Cristina ^a   Wyse, Angela Terezinha de Souza ^a   Schwartz, Ida Vanessa Doederlein ^b   Wajner, Moacir ^a,b   Vargas, Carmen Regla ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Antioxidant defenses; Homocystinuria; Oxidative damage; Oxidative stress; Plasma

Indexed keywords

BETAINE; CARBONYL DERIVATIVE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; MALONALDEHYDE; METHIONINE; PYRIDOXINE; THIOL DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATIONAL STUDY; DIET SUPPLEMENTATION; DIET THERAPY; FEMALE; HOMOCYSTINURIA; HUMAN; MALE; OXIDATIVE STRESS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN RESTRICTION; SCHOOL CHILD; TREATMENT DURATION;

ADOLESCENT; ADULT; ANTIOXIDANTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HOMOCYSTEINE; HOMOCYSTINURIA; HUMANS; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PROTEIN CARBONYLATION; SULFHYDRYL COMPOUNDS; YOUNG ADULT;

EID: 80052546167     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.06.013     Document Type: Article

References (39)

1. Mudd S.H., Levy H.L., Kraus J.P. Disorders of transsulfuration. The Metabolic and Molecular Basis of Inherited Disease 2001, 2007-2056. McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
2. Rao T.N., Radhakrishna K., Rao T.S.M., Guruprasad P., Ahmed K. Homocystinuria due to cystathionine beta synthase deficiency. Indian J. Dermatol. Venereol. Leprol. 2008, 74:375-378.
3. Mudd S.H., Skovby F., Levy H.L., Pettigrew K.D., Wilcken B., Pyeritz R.E., Andria G., Boers G.H., Bromberg I.L., Cerone R., Fowler B., Gröbe H., Schmidt H., Schweitzer L. The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am. J. Hum. Genet. 1985, 37:1-31.
4. Lawson-Yuen A., Levy H.L. The use of betaine in the treatment of elevated homocysteine. Mol. Genet. Metab. 2006, 88:201-207.
5. Wilcken D.E.L., Wilcken B. The natural history of vascular disease in homocystinuria and effects of treatment. J. Inherit. Metab. Dis. 1997, 20:295-300.
6. Lentz S.R. Mechanisms of thrombosis in hyperhomocysteinemia. Curr. Opin. Hematol. 1998, 5:343-349.
7. Halliwell B., Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br. J. Pharmacol. 2004, 142:231-255.
8. Halliwell B., Gutteridge J.M.C. Cellular responses to oxidative stress: adaptation, damage, repair, senescence and death. Free Radicals in Biology and Medicine 2007, 187-267. Oxford University Press, Oxford. B. Halliwell, J.M.C. Gutteridge (Eds.).
9. Starkebaum G., Harlan J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 1986, 77:1370-1376.
10. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J. Clin. Invest. 1996, 98:5-7.
11. Zhang F., Slungaard A., Vercellotti G.M., Iadecola C. Superoxide-dependent cerebrovascular effects of homocysteine. Am. J. Physiol. 1998, 274:R1704-R1711.
12. Faraci F.M., Lentz S.R. Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke 2004, 35:345-347.
13. Streck E.L., Vieira P.S., Wannmacher C.M.D., Dutra-Filho C.S., Wajner M., Wyse A.T.S. In vitro effect of homocysteine on some parameters of oxidative stress in rat hippocampus. Metab. Brain Dis. 2003, 18:147-154.
14. Robert K., Nehmé J., Bourdon E., Pivert G., Friguet B., Delcayre C., Delabar J.M., Janel N. Cystathionine β synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver. Gastroenterology 2005, 128:1405-1415.
15. Matté C., Mackedanz V., Stefanello F.M., Scherer E.B.S., Andreazza A.C., Zanotto C., Moro A.M., Garcia S.C., Gonçalves C.A., Erdtmann B., Salvador M., Wyse A.T.S. Chronic hyperhomocysteinemia alters antioxidant defenses and increases DNA damage in brain and blood of rats: protective effect of folic acid. Neurochem. Int. 2009, 54:7-13.
16. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., Ahn B.W., Shaltiel S., Stadtman E.R. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990, 186:464-478.
17. Aksenov M.Y., Markesbery W.R. Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease. Neurosci. Lett. 2001, 302:141-145.
18. Grotto D., Santa Maria L.D., Boeira S., Valentini J., Charão M.F., Moro A.M., Nascimento P.C., Pomblum V.J., Garcia S.C. Rapid quantification of malondialdehyde in plasma by high performance liquid chromatography-visible detection. J. Pharm. Biomed. Anal. 2007, 43:619-624.
19. Miller N.J., Rice-Evans C., Davies M.J., Gopinathan V., Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin. Sci. 1993, 84:407-412.
20. Yu T.W., Ong C.N. Lag-time measurement of antioxidant capacity using myoglobin and 2,2'-azino-bis(3-ethyl-benzthiazoline-6-sulfonic acid): rationale, application and limitation. Anal. Biochem. 1999, 275:217-223.
21. Magera M.J., Lacey J.M., Casetta B., Rinaldo P. Method for the determination of total homocysteine in plasma and urine by stable isotope dilution and electrospray tandem mass spectrometry. Clin. Chem. 1999, 45:1517-1522.
22. Joseph M.H., Marsden C.A. Amino acids and small peptides. HPLC of Small Peptides 1986, 13-27. IRL Press, Oxford. C.K. Lim (Ed.).
23. Dalle-Donne I., Giustarini D., Colombo R., Rossi R., Milzani A. Protein carbonylation in human diseases. Trends Mol. Med. 2003, 9:169-176.
24. Requejo R., Hurd T.R., Costa N.J., Murphy M.P. Cysteine residues exposed on protein surfaces are the dominant intramitochondrial thiol and may protect against oxidative damage. FEBS J. 2010, 277:1465-1480.
25. Thomas J.A., Poland B., Honzatko R. Protein sulfhydryls and their role in the antioxidant function of protein S-thiolation. Arch. Biochem. Biophys. 1995, 319:1-9.
26. Hansen R.E., Roth D., Winther J.R. Quantifying the global cellular thiol-disulfide status. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:422-427.
27. Lissi E., Salim-Hanna M., Pascual C., del Castillo M.D. Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radic. Biol. Med. 1995, 18:153-158.
28. Longhi R., Rottoli A., Vittorelli A., Zecchini G., Bonabitacola T., Bertassi F., Riva E., Giovannini M. Trace elements nutriture in hyperphenylalaninemic patients: long-term follow up study. Eur. J. Pediatr. 1987, 146:32-37.
29. Sitta A., Barschak A.G., Deon M., de Mari J.F., Barden A.T., Vanzin C.S., Biancini G.B., Schwartz I.V.D., Wajner M., Vargas C.R. L-carnitine blood levels and oxidative stress in treated phenylketonuric patients. Cell. Mol. Neurobiol. 2009, 29:211-218.
30. Jakubowski H. Metabolism of homocysteine thiolactone in human cell cultures. Possible mechanism for pathological consequences of elevated homocysteine levels. J. Biol. Chem. 1997, 272:1935-1942.
31. Jakubowski H. Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans. J. Nutr. 2000, 130:377S-381S.
32. Jakubowski H. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J. 1999, 13:2277-2283.
33. Jakubowski H., Boers G.H.J., Strauss K.A. Mutations in cystathionine β-synthase or methylenetetrahydrofolate reductase gene increase N-homocysteinylated protein levels in humans. FASEB J. 2008, 22:4071-4076.
34. Sibrian-Vazquez M., Escobedo J.O., Lim S., Samoei G.K., Strongin R.M. Homocystamides promote free-radical and oxidative damage to proteins. PNAS 2010, 107:551-554.
35. Chwatko G., Boers G.H.J., Strauss K.A., Shih D.M., Jakubowski H. Mutations in methylenetetrahydrofolate reductase or cystathionine β-syntase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice. FASEB J. 2007, 21:1707-1713.
36. Dudman N.P.B., Wilcken D.E.L. Increased plasma copper in patients with homocystinuria due to cystathionine β-synthase deficiency. Clin. Chim. Acta 1983, 127:105-113.
37. Halliwell B. Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiol. 2006, 141:312-322.
38. Tyagi N., Sedoris K.C., Steed M., Ovechkin A.V., Moshal K.S., Tyagi S.C. Mechanisms of homocysteine-induced oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H2649-H2656.
39. Wu Y., Yang L., Zhong L. Decreased serum levels of thioredoxinin patients with coronary artery disease plus hyperhomocysteinemia is strongly associated with the disease severity. Atherosclerosis 2010, 212:351-355.